Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency. [PDF]
Damanti S +20 more
europepmc +1 more source
Nanomaterials offer dual applications in allergy management. For diagnosis, nanomaterials enhance analytical sensitivity and improve detection in specific IgE and functional assays such as the basophil activation test (BAT). For allergen‐specific immunotherapy, nanomaterials enable allergen masking and controlled release, and effectively modulate the ...
Madiha Habib +8 more
wiley +1 more source
Respiratory insufficiency, feeding issues and length of stay in 33-36 weeks post-menstrual age infants. [PDF]
Bukhari A +5 more
europepmc +1 more source
CHCHD10 loss in Alzheimer's disease is associated with mitochondrial dysfunction, epigenomic disruption, and tau pathology. Restoration of CHCHD10 shifts DNA methylation toward a non‐disease state and reduces tau and amyloid pathology, with KATNAL2 acting as a downstream effector.
Teresa M. Thomas +13 more
wiley +1 more source
Biallelic FGF4 Variants Linked to Thoracic Dystrophy and Respiratory Insufficiency. [PDF]
Watts LM +8 more
europepmc +1 more source
Respiratory Insufficiency in Neuromuscular Disease (RIND): A Delphi Study to Establish Consensus Criteria to Define and Diagnose Hypoventilation in Pediatric Neuromuscular Disease. [PDF]
Mayer OH +5 more
europepmc +1 more source
Tumor Ca2+ interference therapy suffers from self‐protective Ca2+ metabolic autoregulation. In this scenario, a versatile metal‐phenolic nanocluster (TCMH) is engineered to modulate mitochondrial calcium uniporter (MCU) ‐mediated mito‐Ca2+ metabolic autonomy.
Ronglong Chen +13 more
wiley +1 more source
Before Blaming Myosarcoidosis for Respiratory Insufficiency, Cerebral Involvement and Other Causes Should Be Ruled Out. [PDF]
Zarrouk S, Finsterer J.
europepmc +1 more source
Rare causes of respiratory insufficiency in newborns. [PDF]
Brucknerová J +5 more
europepmc +1 more source
Senicapoc treatment in COVID-19 patients with severe respiratory insufficiency-A randomized, open-label, phase II trial. [PDF]
Granfeldt A +14 more
europepmc +1 more source

